Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Integrating breast cancer genomics and proteomics

Next wave of successful drug therapy strategies in HER2-positive breast cancer

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival

How do we design trials that improve outcome?

Breast cancer heterogeneity no barrier to predictive testing

Single cell sequencing techniques in early and late breast cancer

Measurement variation influences gene expression profiles of breast cancer

The future of PI3K/AKT/mTOR inhibitors in breast cancer

The sub-typing of lung cancer and squamous cell carcinoma

Multitarget FISH testing in lung cancer